Drug – bio-affecting and body treating compositions – Topical body preparation containing solid synthetic organic... – Ophthalmic preparation
Patent
1995-04-10
1997-01-28
Azpuru, Carlos
Drug, bio-affecting and body treating compositions
Topical body preparation containing solid synthetic organic...
Ophthalmic preparation
424 7805, 514912, 514914, A61K 3174
Patent
active
055975607
ABSTRACT:
This invention includes a pharmaceutically acceptable formulation of Diclofenac, Tobramycin, a solubility agent and, optionally, excipients, tonicifiers, buffers, viscosity modifying agents, preservatives, and chelating agents, at a pH from greater than 7.0 to about 9. The invention also discloses the use of this pharmaceutically acceptable formulation of an antibiotic and NSAIDs to treat eye and ear conditions accompanied by infection and inflammation.
REFERENCES:
patent: 4087538 (1978-05-01), Portnoff
patent: 4407792 (1983-10-01), Schoenwald et al.
patent: 4478822 (1984-10-01), Hasam et al.
patent: 4668506 (1987-05-01), Bawa
patent: 4829088 (1989-05-01), Doulakas
Human Conjunctivitis, Howard M. Leibowitz, MD, et al., Arch Ophthalmol, vol. 94, Oct. 1976, pp. 1752-1756.
Association diclofenac-dexamethasone dans le traitement de l'inflammation postoperatoire: etude prospective en double-insu, Dr. Philippe Othenin-Girard, et al., Klin. Mbl. Augenheilk, 200, 1992, pp. 362-366.
The Effect of 0.1% Indomethacin Eyedrops on Cataract Surgery, Journal of Ocular Pharmacology, vol. 7, No. 1, 1991, pp. 77-81.
The Effect of Ketorolac Tromethamine in Reducing Postoperative Inflamation: Double-Mask Parallel Comparison with Dexamethasone, Allan J. Flach, MD, et al., Ann Ophthalmol 1989; 21:407-411.
Infections of the Eye--35. Endophthalmitis, David W. Parke II, et al., pp. 563-583.
Incompatibility of indometacin and benzalkonium in eye drops due to ion-pair formation, S. M. Dreijer-Van Der Glas, et al., vol. 9, 1987, Pharmaceutisch Weekblad Scientific Edition, pp. 29-32.
Effects of Pretreatment with Mydriatics on Intraocular Penetration of 0.1% Pranoprofen, Takahiro Ogawa, et al., Jpn J Ophthalmol, vol. 37: 47-55, 1993.
Prediction of Skin Permeability of Drugs: Comparison of Human and Hairless Rat Skin, Yasunori Morimoto, et al., J. Pharm. Pharmacol. 1992, 44: 634-639.
Binary Diclogenac Diethylamine-Water Systems: Micelles, Vesicles and Lyotropic Liquid Crystals, Katrin Kriwet, et al., Eur. J. Pharm. Biopharm, 39 (6) 234-238, 1993.
Degradation of Tobramycin in Aqueous Solution, Michael Brandl and Leo Gu, Drug Development and Industrial Pharmacy, 18(13), 1423-1436, 1992.
Spectrophotometric Method for Determination of Tobramycin, Apramycin and Kanamycin in Formulations, P. R. Bontchev, et al., Mikrochimica Acta (wien) 1984 III, 459-465.
The Top Ten NSAIDs - A molecular modelling study, S. Winiwarter, et al., Pharmaceutica Acta Helvetiae 68 (1994) 181-189.
Conjunctival Disorders, Current Veterinary Therapy X Small Animal Practice, Cecil P. Moore, D.V.M., 1989, pp. 673-678.
A New Corticosteroid-Antibiotic Preparation in Eye and Ear Infections, General Practitioner Clinical Trials, Alexander, J. et al., Jul., 1966, vol. 197: 94-96.
Canine Conjunctiva and Nictitating Membrane, Veterinary Ophthalmology, Dennis E. Brooke, pp. 290-304, 1991.
Diseases of the Ear, Textbook of Veterinary Internal Medicine -- Diseases of the Dog and Cat, vol. I, Dennis W. Macy, pp. 246-257.
American Academy of Ophthalmology, Final Program, Scientific Posters, p. 101.
XXVIIth International Congress of Ophthalmology '94, Final Program, Scientific Papers.
Bergamini Michael V. W.
Cabello Gemma T.
Cabrera Antonio L.
Vallet Mas Jose A.
Azpuru Carlos
Laboratorios Cusi, S.A.
LandOfFree
Diclofenac and tobramycin formulations for ophthalmic and otic t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diclofenac and tobramycin formulations for ophthalmic and otic t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diclofenac and tobramycin formulations for ophthalmic and otic t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-940070